BioTime, Inc. (BTX) financial statements (2020 and earlier)

Company profile

Business Address 2173 SALK AVENUE
CARLSBAD, CA 92008
State of Incorp. CA
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:3131381342295
Cash and cash equivalents924372242295
Short-term investments217     
Other undisclosed cash, cash equivalents, and short-term investments(0)(0)1(10)   
Restricted cash and investments 0     
Receivables24331111
Inventory, net of allowances, customer advances and progress billings    000
Inventory    000
Prepaid expense and other current assets2
Other undisclosed current assets3221242(1)
Total current assets:5836432647328
Noncurrent Assets
Property, plant and equipment8666833
Long-term investments and receivables 22  5  
Long-term investments    5  
Due from related parties 22     
Intangible assets, net (including goodwill)593710343946
Goodwill11      
Intangible assets, net (excluding goodwill)483710343946
Deposits noncurrent assets1111100
Restricted cash and investments 0     
Other noncurrent assets     0 
Other undisclosed noncurrent assets 33117100000
Total noncurrent assets:6865131117474250
TOTAL ASSETS:125102173143957558
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5667977
Accounts payable2212324
Accrued liabilities122353 
Employee-related liabilities222211 
Other undisclosed accounts payable and accrued liabilities0000003
Deferred revenue0
Debt100000 
Deferred revenue and credits01000
Contract with customer, liability0
Other undisclosed current liabilities  0130 
Total current liabilities:67791277
Noncurrent Liabilities
Long-term debt and lease obligation40000  
Long-term debt, excluding current maturities  000  
Finance lease, liability0
Capital lease obligations000   
Operating lease, liability4
Liabilities, other than long-term debt4000159
Deferred revenue and credits00100
Deferred revenue0
Deferred rent credit 0
Deferred tax liabilities, net    58
Deferred income tax liabilities3
Other liabilities   0000
Other undisclosed noncurrent liabilities022250 
Total noncurrent liabilities:8323659
Total liabilities:149912181215
Stockholders' equity
Stockholders' equity attributable to parent11394163118273615
Preferred stock     4 
Common stock387354378318274235203
Treasury stock, value   (3)(18)(20)(43)
Additional paid in capital     00
Accumulated other comprehensive income (loss)(1)10(1)(0)00
Accumulated deficit(273)(262)(216)(196)(229)(182)(146)
Stockholders' equity attributable to noncontrolling interest(2)(2)213502627
Total stockholders' equity:11192164131766342
TOTAL LIABILITIES AND EQUITY:125102173143957558

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues4536754
Revenue, net36754
Cost of revenue(0)(0)(0)(0)(1)(1)(1)
Gross profit:3536644
Operating expenses(42)(46)(44)(65)(72)(55)(60)
Other undisclosed operating income  2    
Operating loss:(39)(42)(39)(59)(66)(51)(56)
Nonoperating income (expense)20(5)16783(0)(0)
Investment income, nonoperating   494  
Foreign currency transaction gain, before tax     00
Other nonoperating income (expense)3(1)1(0)(0)(0)(0)
Interest and debt expense  (3)    
Income (loss) from continuing operations before equity method investments, income taxes:(19)(47)(26)19(63)(51)(56)
Other undisclosed income from continuing operations before income taxes  3    
Income (loss) from continuing operations before income taxes:(19)(47)(23)19(63)(51)(56)
Income tax expense (benefit)(7)0  573
Income (loss) before gain (loss) on sale of properties:(27)(47)(23)19(58)(44)(53)
Other undisclosed net income15      
Net income (loss):(12)(47)(23)19(58)(44)(53)
Net income attributable to noncontrolling interest013  79
Other undisclosed net income attributable to parent   1511  
Net income (loss) attributable to parent:(12)(46)(20)34(47)(36)(44)
Preferred stock dividends and other adjustments    0(0) 
Other undisclosed net loss available to common stockholders, basic    (1)  
Net income (loss) available to common stockholders, diluted:(12)(46)(20)34(47)(36)(44)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(12)(47)(23)19(58)(44)(53)
Other undisclosed comprehensive income (loss)(2) 5141179
Comprehensive income (loss):(14)(47)(19)33(47)(36)(44)
Comprehensive income (loss), net of tax, attributable to noncontrolling interest0(1)3(33)4844(9)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 93(7)18(59)(51) 
Comprehensive income (loss), net of tax, attributable to parent:(14)45(22)18(59)(44)(53)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: